Let-7a suppresses Ewing sarcoma CSCs' malignant phenotype via forming a positive feedback circuit with STAT3 and

Jiang Xu1, Zhongzu Zhang2, Lu Huang3

  • 1Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, PR China.

Journal of Bone Oncology
|December 17, 2021
PubMed

Insights

let-7a microRNA suppresses Ewing Sarcoma cancer stem cells (ES-CSCs) by inhibiting STAT3 and lin28. This discovery offers new therapeutic strategies for treating ES metastasis and recurrence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer stem cells (CSCs) drive tumor metastasis and recurrence in Ewing Sarcoma (ES).
  • Previous studies indicated repressed let-7a expression in ES.
  • Side population (SP) cells in ES exhibit stem cell characteristics and suppressed let-7a.

Purpose of the Study:

  • To investigate the role of let-7a in ES-CSCs.
  • To elucidate the molecular mechanisms underlying let-7a's function in ES-CSCs.
  • To explore potential therapeutic targets for ES treatment.

Main Methods:

  • Separation and identification of ES-CSCs (SP cells).
  • Manipulation of let-7a expression in ES-CSCs.
  • In vitro assays for colony formation and invasion.
  • In vivo xenograft mouse models.
  • Analysis of STAT3 and lin28 expression and their roles.

Main Results:

  • Increased let-7a expression suppressed ES-CSC colony formation and invasion in vitro and tumor growth in vivo.
  • let-7a suppressed STAT3 expression; STAT3 inhibition mimicked let-7a's suppressive effects.
  • A positive feedback circuit involving let-7a, STAT3, and lin28 was identified in ES-CSCs.

Conclusions:

  • let-7a plays a critical role in regulating ES-CSC behavior.
  • The let-7a/STAT3/lin28 feedback loop is pivotal in ES-CSC carcinogenesis.
  • Targeting this pathway may offer new therapeutic avenues for ES, particularly for metastatic and recurrent cases.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K